Smoking Cessation Clinical Trial
Official title:
Nicotinic Receptor Availability and Smoking Cessation Success.
The investigators propose to use positron emission tomography (PET) imaging to determine whether nicotinic receptor availability at pretreatment predicts smoking cessation success. The investigators will recruit 30 smokers from those enrolled in the Pharmacogenetics of Nicotine Addiction Treatment clinical trial. The investigators will measure nicotinic receptor availability using the PET radioligand 2-[18F]FA, after overnight abstinence and prior to initiation of treatment.
Subjects will be asked to complete a short screening session, an orientation phone call, and
two imaging sessions: one PET imaging session and one MRI session.
Intake Session. This session will familiarize subjects with the study procedures and risks,
as well as determine initial eligibility for the study. Subjects will first complete an
Imaging Screening Form with study personnel. Subjects will also complete a Magnet Safety Form
to check for any metal in the body. Finally, subjects will complete a Scanning Registration
Form.
Orientation Call. Dr. Dubroff (the Principal Investigator and study physician) will call
subjects before the PET Scan Session to review the study procedures and risks and answer any
questions subjects might have.
PET Scan Session. Subjects will receive a telephone call the day before the session to remind
them to stop smoking at 9:00pm that night. At the session, they will provide a series of
samples. These include:
- A urine sample to assess for the presence of study-prohibited drugs and medications
(including cocaine, opiates, benzodiazepines, amphetamines, methamphetamines, tri-cyclic
antidepressants, methadone, PCP, and barbiturates).
- Women of childbearing age will be required to take a urine pregnancy test.
- A breath alcohol concentration (BrAC) measurement.
- A breath carbon monoxide (CO) reading.
- Have your weight measured.
After subjects arrive at the PET center, they will have two intravenous (I.V.) lines placed.
A sterile solution will be dripped through the tubing to keep them open. Subjects will have
blood pressure and heart rate taken prior to injection and three 10ml tubes of blood will be
drawn to determine the baseline levels of radioactive tracer. After this, subjects will be
injected with a radioactive tracer (a chemical that has a radioactive molecule attached to
it) called 2-[18F]FA that will be pumped through one of the I.V. lines over an 8-hour period.
During the waiting period subjects will complete two questionnaires, a brief IQ test, and
five computer games. They will have repeated blood pressure and heart rate readings taken
soon after the initial injection and every 45 minutes afterwards. The investigators will draw
3 ml (half a teaspoon) of blood from the second I.V. line every 15-30 minutes to measure
radiotracer levels.
Just prior to beginning the scan, subjects will be asked two questions about cravings. These
questions will be asked every 30 minutes during the scan and then once more after subjects
have exited the scan. The investigators will draw one 3ml tube of blood at the beginning of
the PET scan and every 30 min during the PET scan (total 5 teaspoons) from the second I.V.
line to measure radiotracer levels.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04043728 -
Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study
|
N/A | |
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT04617444 -
The ESTxENDS Trial- Substudy on Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Olfactory Function
|
N/A | |
Completed |
NCT02796391 -
Facilitating Smoking Cessation With Reduced Nicotine Cigarettes
|
Phase 2 | |
Completed |
NCT03397511 -
Incorporating Financial Incentives to Increase Smoking Cessation Among Asian Americans Residing in New York City
|
N/A | |
Not yet recruiting |
NCT05188287 -
A Culturally Tailored Smartphone Application for African American Smokers
|
N/A | |
Recruiting |
NCT05264428 -
The Effect of Honey on Lessening the Withdrawal Symptoms
|
N/A | |
Recruiting |
NCT05846841 -
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
|
N/A | |
Completed |
NCT04133064 -
Assessment of the Pivot Breath Sensor: Single-Arm Cohort Study
|
N/A | |
Completed |
NCT03187730 -
Integrating Financial Management Counseling and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants
|
Phase 4 | |
Completed |
NCT03474783 -
To Explore the Factors Affecting the Effectiveness of Smoking Cessation
|
N/A | |
Completed |
NCT04635358 -
Feasibility Study of Smoking Cessation for the Staff of a Hospital Center
|
N/A | |
Terminated |
NCT03670264 -
BE Smokefree: Behavioral Economics Incentives to Engage Adolescents in Smoking Cessation
|
N/A | |
Not yet recruiting |
NCT06307496 -
VIDeOS for Smoking Cessation
|
N/A | |
Completed |
NCT03206619 -
A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
|
||
Completed |
NCT02905656 -
Strategies to Promote Cessation in Smokers Who Are Not Ready To Quit
|
N/A | |
Completed |
NCT02997657 -
Positive Psychotherapy for Smoking Cessation Enhanced With Text Messaging: A Randomized Controlled Trial
|
N/A | |
Completed |
NCT02239770 -
Pharmacokinetics of Nicotine Film in Smokers
|
N/A | |
Completed |
NCT02562521 -
A Smoking Cessation Intervention for Yale Dining Employees
|
Phase 4 | |
Recruiting |
NCT02422914 -
Benefits of Tobacco Free Cigarette
|
N/A |